| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Edward H Schuchman | Q92756224 |
| P2093 | author name string | Jae-Ho Park | |
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2133-2138 | |
| P577 | publication date | 2006-09-01 | |
| P1433 | published in | Biochimica et Biophysica Acta | Q864239 |
| P1476 | title | Acid ceramidase and human disease | |
| P478 | volume | 1758 |
| Q26866012 | A central role for the acid sphingomyelinase/ceramide system in neurogenesis and major depression |
| Q53045937 | A fluorescent probe for imaging symmetric and asymmetric cell division in neurosphere formation. |
| Q89944674 | Acid Ceramidase Depletion Impairs Neuronal Survival and Induces Morphological Defects in Neurites Associated with Altered Gene Transcription and Sphingolipid Content |
| Q35938653 | Acid Sphingomyelinase Mediates Oxidized-LDL Induced Apoptosis in Macrophage via Endoplasmic Reticulum Stress |
| Q35744011 | Acid ceramidase (ASAH1) is a global regulator of steroidogenic capacity and adrenocortical gene expression |
| Q36362832 | Acid ceramidase (ASAH1) represses steroidogenic factor 1-dependent gene transcription in H295R human adrenocortical cells by binding to the receptor |
| Q47852896 | Acid ceramidase and its inhibitors: a de novo drug target and a new class of drugs for killing glioblastoma cancer stem cells with high efficiency |
| Q46460410 | Acid ceramidase confers radioresistance to glioblastoma cells |
| Q51734741 | Acid ceramidase inhibition ameliorates α-synuclein accumulation upon loss of GBA1 function. |
| Q30275460 | Acid ceramidase is upregulated in AML and represents a novel therapeutic target |
| Q36706155 | Acid ceramidase treatment enhances the outcome of autologous chondrocyte implantation in a rat osteochondral defect model. |
| Q37486242 | Acid ceramidase upregulation in prostate cancer: role in tumor development and implications for therapy |
| Q35749511 | Activity of neutral and alkaline ceramidases on fluorogenic N-acylated coumarin-containing aminodiols. |
| Q37079752 | Akt2 and acid ceramidase cooperate to induce cell invasion and resistance to apoptosis |
| Q28487758 | Analysis of the membrane proteome of ciprofloxacin-resistant macrophages by stable isotope labeling with amino acids in cell culture (SILAC) |
| Q64763405 | Autophagy in Synucleinopathy: The Overwhelmed and Defective Machinery |
| Q26828523 | Autophagy paradox and ceramide |
| Q39262060 | Autoproteolytic cleavage and activation of human acid ceramidase |
| Q41094126 | C26-Ceramide as highly sensitive biomarker for the diagnosis of Farber Disease |
| Q37129849 | Cell-centric view of apoptosis and apoptotic cell death-inducing antitumoral strategies |
| Q37688315 | Ceramide and ceramide 1-phosphate in health and disease. |
| Q28074507 | Ceramide as a Target of Marine Triterpene Glycosides for Treatment of Human Myeloid Leukemia |
| Q46533820 | Ceranib-2-induced suicidal erythrocyte death |
| Q30986319 | Compartmentalization of the Edinburgh Human Metabolic Network |
| Q40091584 | Complete Acid Ceramidase ablation prevents cancer-initiating cell formation in melanoma cells |
| Q37091180 | Construction of conditional acid ceramidase knockout mice and in vivo effects on oocyte development and fertility |
| Q47170906 | Dietary and Endogenous Sphingolipid Metabolism in Chronic Inflammation |
| Q47333736 | Differences in global gene expression in muscle tissue of Nellore cattle with divergent meat tenderness. |
| Q35597630 | Disruption of sphingolipid metabolism augments ceramide-induced autophagy in preeclampsia |
| Q30278944 | Dynamics of ceramide generation and metabolism in response to fenretinide--Diversity within and among leukemia |
| Q44413471 | Evidence for clinical, genetic and biochemical variability in spinal muscular atrophy with progressive myoclonic epilepsy. |
| Q96303459 | Exploring Sphingolipid Implications in Neurodegeneration |
| Q37188548 | Farber disease: understanding a fatal childhood disorder and dissecting ceramide biology. |
| Q35217762 | Gene expression profiling in pachyonychia congenita skin |
| Q55646357 | Genetic Variation in Acid Ceramidase Predicts Non-completion of an Exercise Intervention. |
| Q90395580 | Glucocerebrosidase: Functions in and Beyond the Lysosome |
| Q55342124 | Identification of radiation responsive genes and transcriptome profiling via complete RNA sequencing in a stable radioresistant U87 glioblastoma model. |
| Q51810935 | Identification of the N-acylsphingosine amidohydrolase 1 gene (ASAH1) for susceptibility to schizophrenia in a Han Chinese population. |
| Q34674948 | Increased oxidative stress impairs adipose tissue function in sphingomyelin synthase 1 null mice |
| Q49598164 | Inhibition of Acid Sphingomyelinase Disrupts LYNUS Signaling and Triggers Autophagy |
| Q38773771 | Interaction of acid ceramidase inhibitor LCL521 with tumor response to photodynamic therapy and photodynamic therapy-generated vaccine |
| Q64973473 | Interdiction of Sphingolipid Metabolism Revisited: Focus on Prostate Cancer. |
| Q91736508 | Lysosomal acid ceramidase ASAH1 controls the transition between invasive and proliferative phenotype in melanoma cells |
| Q37025638 | Medicinal chemistry aspects of drug targets in sphingolipid metabolism |
| Q90331140 | Molecular Mechanism of Inhibition of Acid Ceramidase by Carmofur |
| Q37493639 | Molecular mechanism for sphingosine-induced Pseudomonas ceramidase expression through the transcriptional regulator SphR. |
| Q36787581 | Molecular profiling of LGL leukemia reveals role of sphingolipid signaling in survival of cytotoxic lymphocytes |
| Q37239617 | Molecular targeting of acid ceramidase: implications to cancer therapy. |
| Q37373721 | More surprises lying ahead. The endocannabinoids keep us guessing |
| Q33902037 | Multi-system disorders of glycosphingolipid and ganglioside metabolism |
| Q37602880 | Never say die: survival signaling in large granular lymphocyte leukemia |
| Q55432540 | Opposing roles of microRNA Argonautes during Caenorhabditis elegans aging. |
| Q40085782 | Plasma and ovarian tissue sphingolipids profiling in patients with advanced ovarian cancer |
| Q90475746 | Podocytopathy and Nephrotic Syndrome in Mice with Podocyte-Specific Deletion of the Asah1 Gene: Role of Ceramide Accumulation in Glomeruli |
| Q39221676 | Potential role of acid ceramidase in conversion of cytostatic to cytotoxic end-point in pancreatic cancer cells. |
| Q35867831 | Protein profiling of human lung telocytes and microvascular endothelial cells using iTRAQ quantitative proteomics |
| Q33730375 | Recent advances on the molecular mechanisms involved in the drug resistance of cancer cells and novel targeting therapies |
| Q34787157 | Regulation of CC ligand 5/RANTES by acid sphingomyelinase and acid ceramidase |
| Q38495744 | Role of Sphingolipids and Metabolizing Enzymes in Hematological Malignancies |
| Q24657499 | Roles of bioactive sphingolipids in cancer biology and therapeutics |
| Q92129011 | Sphingolipid/Ceramide Pathways and Autophagy in the Onset and Progression of Melanoma: Novel Therapeutic Targets and Opportunities |
| Q37808219 | Sphingolipids and cancer: ceramide and sphingosine-1-phosphate in the regulation of cell death and drug resistance |
| Q36459028 | Sphingolipids and membrane biology as determined from genetic models |
| Q38332040 | Sphingolipids and mitochondrial apoptosis |
| Q38809404 | Sphingolipids in mitochondria. |
| Q44965785 | Sphingolipids in the lungs. |
| Q41531207 | Sphingosine Kinases and Sphingosine 1-Phosphate Receptors: Signaling and Actions in the Cardiovascular System |
| Q39654212 | Synthesis, NMR characterization and divergent biological actions of 2'-hydroxy-ceramide/dihydroceramide stereoisomers in MCF7 cells. |
| Q37188558 | Systemic ceramide accumulation leads to severe and varied pathological consequences. |
| Q37042046 | T-cell and natural killer-cell large granular lymphocyte leukemia neoplasias |
| Q41530002 | The Arabidopsis ceramidase AtACER functions in disease resistance and salt tolerance |
| Q34453044 | The identification of the endogenous ligands of natural killer T cells reveals the presence of mammalian α-linked glycosylceramides |
| Q38506608 | The secreted proteome profile of developing Dictyostelium discoideum cells |
| Q24642219 | The sphingolipid salvage pathway in ceramide metabolism and signaling |
| Q39420607 | Therapeutic implications of bioactive sphingolipids: A focus on colorectal cancer |
Search more.